Abstract: Hypoglycemia is the most common but highly feared complication induced by the intensive insulin therapy in patients with type 1 diabetes mellitus (T1DM). Nocturnal hypoglycemia is dangerous ...

If you have type 1 diabetes or type 2 diabetes that you manage with insulin, you could be at risk of hypoglycemia unawareness. The condition can happen when you use insulin or other diabetes ...

Hypoglycemia is linked to an increased risk for and progression of diabetic retinopathy, according to new research presented at The Retina Society (TRS) Annual Meeting 2025. Severe hypoglycemia is ...

Worsening CKD was progressively associated with denosumab-induced hypocalcemia warranting emergency treatment. Denosumab use carries a higher risk for emergency hypocalcemia compared with ...

Please provide your email address to receive an email when new articles are posted on . Hypocalcemia risk increased with worsening CKD stages, particularly for patients on dialysis. Emergently treated ...

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which ...

In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...

Hypoglycemia is common in childhood with long-term neurodisability from irreversible neuronal injury; yet the problem remains obdurately unresolved. The Research Topic series “The Problem of Childhood ...

Three new books warn against turning into the person the algorithm thinks you are. Like a lot of Netflix subscribers, I find that my personal feed tends to be hit or miss. Usually more miss. The ...

Williams is Assistant Professor of Communication and Digital Studies at the University of Michigan, Senior Fellow in Trustworthy AI at the Mozilla Foundation, and Faculty Associate at Harvard ...

The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued a boxed warning stating denosumab increases severe hypocalcemia risk for adults with advanced CKD ...